Search

Austin Murata

Examiner (ID: 10706, Phone: (571)270-5596 , Office: P/1712 )

Most Active Art Unit
1712
Art Unit(s)
1792, 1712
Total Applications
876
Issued Applications
484
Pending Applications
86
Abandoned Applications
318

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7461329 [patent_doc_number] => 20040197839 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Methods of detecting cancer cells in biological samples' [patent_app_type] => new [patent_app_number] => 10/771440 [patent_app_country] => US [patent_app_date] => 2004-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12941 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20040197839.pdf [firstpage_image] =>[orig_patent_app_number] => 10771440 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/771440
Methods of detecting cancer cells in biological samples Feb 4, 2004 Abandoned
Array ( [id] => 7233608 [patent_doc_number] => 20040157227 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-12 [patent_title] => 'Reproductive cancer diagnosis and therapy' [patent_app_type] => new [patent_app_number] => 10/477506 [patent_app_country] => US [patent_app_date] => 2004-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11060 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20040157227.pdf [firstpage_image] =>[orig_patent_app_number] => 10477506 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/477506
Reproductive cancer diagnosis and therapy Feb 3, 2004 Abandoned
Array ( [id] => 5770286 [patent_doc_number] => 20050266409 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Compositions and methods for diagnosing, preventing, and treating cancers' [patent_app_type] => utility [patent_app_number] => 10/770726 [patent_app_country] => US [patent_app_date] => 2004-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 45620 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20050266409.pdf [firstpage_image] =>[orig_patent_app_number] => 10770726 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/770726
Compositions and methods for diagnosing, preventing, and treating cancers Feb 3, 2004 Abandoned
Array ( [id] => 7286854 [patent_doc_number] => 20040146921 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => 'Expression profiles for colon cancer and methods of use' [patent_app_type] => new [patent_app_number] => 10/764425 [patent_app_country] => US [patent_app_date] => 2004-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21411 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20040146921.pdf [firstpage_image] =>[orig_patent_app_number] => 10764425 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/764425
Expression profiles for colon cancer and methods of use Jan 22, 2004 Abandoned
Array ( [id] => 9589561 [patent_doc_number] => 08779102 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-15 [patent_title] => 'Recognition molecules for the treatment and detection of tumors' [patent_app_type] => utility [patent_app_number] => 10/540479 [patent_app_country] => US [patent_app_date] => 2004-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 23113 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10540479 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/540479
Recognition molecules for the treatment and detection of tumors Jan 22, 2004 Issued
Array ( [id] => 7097240 [patent_doc_number] => 20050129698 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'Polypeptides (MBP1) capable of interacting with oncogenic mutants of the p53 protein' [patent_app_type] => utility [patent_app_number] => 10/759256 [patent_app_country] => US [patent_app_date] => 2004-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13914 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20050129698.pdf [firstpage_image] =>[orig_patent_app_number] => 10759256 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/759256
Polypeptides (MBP1) capable of interacting with oncogenic mutants of the p53 protein Jan 19, 2004 Abandoned
Array ( [id] => 5119934 [patent_doc_number] => 20070141648 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Flj10607 as modifier of the axin pathway and methods of use' [patent_app_type] => utility [patent_app_number] => 10/535443 [patent_app_country] => US [patent_app_date] => 2003-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15550 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20070141648.pdf [firstpage_image] =>[orig_patent_app_number] => 10535443 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/535443
Flj10607 as modifier of the axin pathway and methods of use Dec 28, 2003 Abandoned
Array ( [id] => 5747462 [patent_doc_number] => 20060110393 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-25 [patent_title] => 'Novel proteins and use thereof' [patent_app_type] => utility [patent_app_number] => 10/540394 [patent_app_country] => US [patent_app_date] => 2003-12-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34128 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20060110393.pdf [firstpage_image] =>[orig_patent_app_number] => 10540394 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/540394
Novel proteins and use thereof Dec 24, 2003 Abandoned
Array ( [id] => 5704805 [patent_doc_number] => 20060193853 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Combinations of growth-and hormone-regulating factors for the treatment of neoplasia' [patent_app_type] => utility [patent_app_number] => 10/539172 [patent_app_country] => US [patent_app_date] => 2003-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4097 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20060193853.pdf [firstpage_image] =>[orig_patent_app_number] => 10539172 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/539172
Combinations of growth-and hormone-regulating factors for the treatment of neoplasia Dec 21, 2003 Abandoned
Array ( [id] => 7311098 [patent_doc_number] => 20040143111 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Novel apoptosis-associated protein' [patent_app_type] => new [patent_app_number] => 10/741201 [patent_app_country] => US [patent_app_date] => 2003-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 18140 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20040143111.pdf [firstpage_image] =>[orig_patent_app_number] => 10741201 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/741201
Novel apoptosis-associated protein Dec 18, 2003 Abandoned
Array ( [id] => 7466066 [patent_doc_number] => 20040198661 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof' [patent_app_type] => new [patent_app_number] => 10/736188 [patent_app_country] => US [patent_app_date] => 2003-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 11131 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20040198661.pdf [firstpage_image] =>[orig_patent_app_number] => 10736188 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/736188
Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof Dec 14, 2003 Abandoned
Array ( [id] => 7074344 [patent_doc_number] => 20050147612 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-07 [patent_title] => 'Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/734661 [patent_app_country] => US [patent_app_date] => 2003-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 21506 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20050147612.pdf [firstpage_image] =>[orig_patent_app_number] => 10734661 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/734661
Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof Dec 14, 2003 Issued
Array ( [id] => 7675732 [patent_doc_number] => 20040126386 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'P53 vaccine' [patent_app_type] => new [patent_app_number] => 10/734476 [patent_app_country] => US [patent_app_date] => 2003-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 11353 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0126/20040126386.pdf [firstpage_image] =>[orig_patent_app_number] => 10734476 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/734476
P53 vaccine Dec 11, 2003 Abandoned
Array ( [id] => 7423101 [patent_doc_number] => 20040265307 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Anti-IGF-I receptor antibody' [patent_app_type] => new [patent_app_number] => 10/729441 [patent_app_country] => US [patent_app_date] => 2003-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 20406 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20040265307.pdf [firstpage_image] =>[orig_patent_app_number] => 10729441 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/729441
Anti-IGF-I receptor antibody Dec 7, 2003 Issued
Array ( [id] => 7339501 [patent_doc_number] => 20040133357 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Humanized antibodies against vascular endothelial growth factor' [patent_app_type] => new [patent_app_number] => 10/723434 [patent_app_country] => US [patent_app_date] => 2003-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 29100 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0133/20040133357.pdf [firstpage_image] =>[orig_patent_app_number] => 10723434 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/723434
Humanized antibodies against vascular endothelial growth factor Nov 25, 2003 Issued
Array ( [id] => 7033108 [patent_doc_number] => 20050031617 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Antibodies specific for cancer associated antigen SM5-1 and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/722849 [patent_app_country] => US [patent_app_date] => 2003-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 21931 [patent_no_of_claims] => 74 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20050031617.pdf [firstpage_image] =>[orig_patent_app_number] => 10722849 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/722849
Antibodies specific for cancer associated antigen SM5-1 and uses thereof Nov 25, 2003 Abandoned
Array ( [id] => 7170461 [patent_doc_number] => 20040077843 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'Antibody/receptor targeting moiety for enhanced delivery of armed ligand' [patent_app_type] => new [patent_app_number] => 10/718534 [patent_app_country] => US [patent_app_date] => 2003-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8633 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20040077843.pdf [firstpage_image] =>[orig_patent_app_number] => 10718534 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/718534
Antibody/receptor targeting moiety for enhanced delivery of armed ligand Nov 23, 2003 Abandoned
Array ( [id] => 7449352 [patent_doc_number] => 20040067542 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-08 [patent_title] => 'P2y purinergic receptor expression for identifying preneoplastic and neoplastic states' [patent_app_type] => new [patent_app_number] => 10/450205 [patent_app_country] => US [patent_app_date] => 2003-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5243 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 29 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0067/20040067542.pdf [firstpage_image] =>[orig_patent_app_number] => 10450205 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/450205
P2y purinergic receptor expression for identifying preneoplastic and neoplastic states Nov 13, 2003 Abandoned
Array ( [id] => 5595775 [patent_doc_number] => 20060159691 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Ptprk immunogenic peptide' [patent_app_type] => utility [patent_app_number] => 10/534864 [patent_app_country] => US [patent_app_date] => 2003-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7001 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20060159691.pdf [firstpage_image] =>[orig_patent_app_number] => 10534864 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/534864
Ptprk immunogenic peptide Nov 11, 2003 Abandoned
Array ( [id] => 7407740 [patent_doc_number] => 20040106141 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-03 [patent_title] => 'Methods and materials for examining pathways associated with glioblastoma progression' [patent_app_type] => new [patent_app_number] => 10/701490 [patent_app_country] => US [patent_app_date] => 2003-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17930 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20040106141.pdf [firstpage_image] =>[orig_patent_app_number] => 10701490 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/701490
Methods and materials for examining pathways associated with glioblastoma progression Nov 4, 2003 Abandoned
Menu